Oklo is trading at $44.81, down -7.45%, amid broader valuation and milestone-related pressure.

  • No new company-specific announcement explaining the August 10 decline was identified; coverage cites no single confirmed catalyst.
  • The move follows Friday’s 14.77% rally after Q2 results and Groves reactor criticality news.
  • Q2 news was mixed: revenue beat expectations, but losses widened and spending guidance increased.